Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability Study of Infacort® Versus Cortef® in Healthy Subjects
NCT03311932Phase 1Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Apr 2018
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hydrocortisone in adrenal insufficiency (AI) (4 arms), sponsored by Neurocrine Biosciences. Primary endpoints: Maximum serum concentration, Area under the serum cortisol concentration-time curve and 1 more. Started Apr 2018; status: completed.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT03311932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03311932.